一个细胞模型提供了关于致癌性FOXL2体质变异p.Cys134Trp致病性的见解
Laetitia Herman1, Angélique Amo1, Berangère Legois1
1Université Paris Cité, CNRS, Institut Jacques Monod, Paris, France.
British journal of cancer
|March 1, 2024
概括
在颗粒细胞瘤中常见的FOXL2 (分叉盒L2) 基因变异,通过功能增益机制驱动癌症的进展. 这种突变的FOXL2增强了与SMAD3的相互作用,影响了细胞行为.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 癌症研究 癌症研究
背景情况:
- FOXL2是一种转录因子,对卵巢颗粒细胞功能至关重要.
- 一种特定的FOXL2体型变异 (p.Cys134Trp) 是成年型粒状细胞瘤的关键标志物.
研究的目的:
- 为了研究FOXL2变体在颗粒细胞瘤中的功能增益 (GOF) 机制.
- 为了确定受突变FOXL2.2影响的途径和分子相互作用.
主要方法:
- 通过CRISPR/Cas9基因编辑,创建FOXL2变体 (MUT) 和野生型 (WT) KGN细胞系.
- 用RNA测序和生物信息学分析来识别差异表达基因 (DEGs).
- 细胞形态,迁移测定和蛋白质相互作用研究 (SMAD3,SMAD4).
主要成果:
- 该FOXL2变体失调了包括TGF-β信号传递,细胞粘附和迁移在内的通路.
- 与WT细胞相比,MUT细胞表现出改变的形态和应力纤维分布.
- 在MUT细胞中差异表达的基因与FOXL2淘汰细胞中的基因在很大程度上不同,支持GOF模型.
- 突变的FOXL2显示与SMAD3.3的相互作用增加.
结论:
- 这项研究支持在粒状细胞瘤中的FOXL2变体的功能增益模型.
- 与SMAD3的增强相互作用是突变FOXL2的致癌活性的一个潜在机制.
- 突变的FOXL2可能会获得结合SMAD4的能力,从而导致瘤发生.
更多相关视频
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
9.7K
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.8K
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Cystic Fibrosis: Pathogenesis
239
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
239
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
